Clinical Trial Update: Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma [Phase 2]

View source ↗

Summary

Phase 2 dose-ranging trial evaluating efficacy and safety of mepolizumab in adults with severe asthma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Mepolizumab (mepolizumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2016-02-05